VectorialDATA
Stocks/ESLOY

ESLOY — EssilorLuxottica

Consumer DiscretionaryEuropeFranceBlockchain certified

Price when we picked it (Apr 15, 2026)

$122.75

Target: $165.00 (+34.4%)

P/E Ratio

41.9

P/E Forward

25.6

Dividend

1.87%

Market Cap

$112.9B

EPS

$2.93

Consensus

Buy

What they do

EssilorLuxottica is the French-Italian giant that dominates the entire eyewear value chain. They make the lenses (Essilor: Varilux, Transitions, Crizal, Kodak Lens), design and produce the frames (Luxottica: Ray-Ban, Oakley, Persol, Oliver Peoples, Vogue Eyewear, Arnette, Costa Del Mar, Alain Mikli), hold exclusive licenses for luxury brands (Prada, Chanel, Tiffany, Versace, Burberry, Dolce & Gabbana, Michael Kors, Coach, Ralph Lauren, Giorgio Armani), and own the stores where you buy them (LensCrafters, Sunglass Hut, Pearle Vision, Target Optical, Apex). They also own EyeMed, the #2 vision insurer in the US, completing the cycle: they insure you, examine you, sell you the frames, make the lenses, and deliver them to you. Total vertical integration. The big new growth driver is Ray-Ban Meta — the AI smart glasses they develop with Meta. They sold 7 million units in 2025 (compared to 2M combined in 2023+2024). In 2026, they launch Oakley and Prada versions, expanding the bet.

Why we like it

FY2025 was a record year: revenue €28.5B (+11.2% YoY, first double-digit growth in company history at constant exchange rates), Q4 accelerating to +18.4%, adjusted operating margin 16.0%, record free cash flow of €2.8B despite tariffs and currency. Ray-Ban Meta is the 'dominant driver' of wholesale growth — and the smart glasses market is projected to grow from 6M units in 2025 to 20M in 2026 (value from $1.2B to $5.6B). The stock fell from the 52-week high of $186.81 to $122.75 (-34%) due to fears of Apple competition (Apple's smart glasses won't arrive until 2027) and Trump tariffs — temporary challenges in a business with a near-structural monopoly. Wall Street analysts expect significant upside: 19-22 Buy / 1-2 Hold / 0-1 Sell. Eyewear isn't fashion — it's a recurring, non-discretionary expense: 2.5B people worldwide use corrective lenses and replace them every 2-3 years. Stable demand, strong pricing power, and now a growth boost via AI wearables.

Key Risk

Apple's competition in smart glasses (production expected December 2026, launch 2027) threatens Ray-Ban Meta's current advantage — the main trigger for the 34% drop from highs. If Apple captures market share with a 'better-made' product (according to Bloomberg leaks), EssilorLuxottica loses the premium that currently supports its best growth story. Other risks: Trump tariffs of up to 20% on European imports and 36% on Thailand hit US margins (40% of revenue); a class action was filed in February 2026 over price hikes post-tariffs; Warby Parker and direct-to-consumer models erode share in entry-level optics. The price vs. profit ratio of 41.89x leaves little room if earnings disappoint.

This is educational and informational content, not financial advice. Always consult a qualified financial advisor before making investment decisions.

Vectorial Data picked ESLOY on Apr 15, 2026 at $122.75.

Full Research

EssilorLuxottica (ESLOY) — Complete Research

Price: $122.75 | P/E: 41.89 | P/E Forward: 25.56 | Div Yield: 1.87% | Market Cap: $112.9B

Note: ESLOY is the ADR OTC. The primary stock trades on Euronext Paris as EL.PA (1 ESLOY ≈ 0.25 EL.PA).


What It Is

EssilorLuxottica is the global monopoly on eyewear — the result of the 2018 merger between Essilor (French lenses, #1 worldwide in ophthalmic lenses) and Luxottica (Italian frames, #1 worldwide in frames). The group controls ~60% of the eyewear market in the US and has a comparable global share. In corrective lenses specifically, they hold 42% of the global market share.

It's not just a lens company. It's a complete vertical ecosystem: they design, manufacture, license, distribute, retail, and insure. If you have glasses on your face, they probably came from some part of this company.

Business Model — Total Vertical Integration

Own Brands (Luxottica)

BrandSegment
Ray-BanIconic, mass-premium, smart glasses
OakleySports, performance, new Meta AI line
PersolPremium Italian, handmade
Oliver PeoplesLuxury Californian
Vogue EyewearAccessible women's fashion
ArnetteYouthful, action sports
Costa Del MarFishing, outdoor premium
Alain MikliHaute couture

Luxury Licenses

Exclusive licenses with Prada, Chanel, Tiffany, Versace, Burberry, Dolce & Gabbana, Michael Kors, Coach, Ralph Lauren, Giorgio Armani, Brunello Cucinelli, Miu Miu, Tory Burch and more. The renewal with Prada in December 2025 was for 10 years.

Lenses (Essilor)

BrandSpecialty
Varilux#1 worldwide in progressive lenses
TransitionsPhotochromic (adapt to sunlight)
CrizalPremium anti-reflective
Kodak LensLicensed mass brand

Own Retail

ChainReach
LensCrafters~1,300 stores in the US
Sunglass Hut~2,700 stores globally
Pearle Vision~500 stores in the US
Target OpticalWithin-Target
Apex by Sunglass HutPremium sunglasses
Ray-Ban StoresGlobal flagship stores

Insurance

EyeMed — the second-largest vision insurer in the US. Closes the loop: insures you, examines you, sells you the frames, makes the lenses, collects insurance.

The Catalyst: Ray-Ban Meta (Smart Glasses)

Partnership with Meta Platforms — renewed and expanded in 2024 for $5B and an additional 10 years.

Impressive Numbers

  • 7 million units sold in 2025 (Ray-Ban Meta + Oakley Meta)
  • vs 2 million combined in 2023+2024 → +250% YoY
  • Described by the company as "the dominant driver" of wholesale growth

Exploding Market

  • 2025: 6M units / $1.2B market
  • 2026 projected: 20M units / $5.6B market
  • EssilorLuxottica + Meta have the technical and distribution lead

2026 Expansion

  • Oakley Meta HSTN — sports version, ~$360, weather-resistant (already launched)
  • Prada Meta — first luxury fashion brand in smart glasses (leaked 2026)
  • Next generations with integrated display (Bloomberg rumor 2026)

FY2025 Results — Historic Record

MetricValuevs 2024
Revenue€28,491M+11.2% (constant FX)
Q4 Revenue growth+18.4%Acceleration
Adj. Operating Margin16.0%—
Adj. Operating Profit€4.5BRecord
Free Cash Flow€2.796BHistoric record
Net Income~€2.4B—
First year in EssilorLuxottica's history with double-digit annual growth at constant exchange rates.

Why Now

1. The Drop is a Gift

  • 52w High: $186.81
  • Current price: $122.75 → -34% from highs
  • Reason for the drop: fear of Apple smart glasses + Trump tariffs + rotation out of European luxury
  • Apple doesn't launch until 2027 — EssilorLuxottica has 18+ months of advantage

2. Real Monopoly with Pricing Power

  • 60% US share, 42% global in corrective lenses
  • Can pass tariffs to consumers without losing customers
  • 2.5B people worldwide use glasses — non-discretionary demand

3. Ray-Ban Meta is a New Business

  • High margin, triple-digit growth
  • Meta pays for R&D; EssilorLuxottica provides distribution and brand
  • Oakley and Prada extensions multiply the TAM in 2026

4. Solid 2026 Guidance

  • Revenue: €27-28B
  • Operating margin: 19-20% (improvement from 16% in 2025)
  • Mid-single-digit growth confirmed despite tariffs

Financial Metrics

MetricValue
ADR Price (ESLOY)$122.75
Market Cap$112.9B
P/E TTM41.89x
P/E Forward25.56x
EPS TTM$2.93
Dividend Yield1.87%
Dividend Rate$2.25
52w High$186.81
52w Low$109.00
Drawdown from high-34%

Analyst Consensus

MetricValue
ConsensusBuy
Analysts Buy19-22
Analysts Hold1-2
Analysts Sell0-1
Average Target (EL.PA)€318-326
Estimated ADR Target~$165
Upside ADR from $122.75+34.4%

Risks

1. Apple Smart Glasses (the big bear case)

  • Production Dec 2026, launch spring/summer 2027
  • Rumored pricing: $499-$799 (premium vs Ray-Ban Meta)
  • Bloomberg leak: "similar to Meta product but better built"

2. Trump Tariffs

  • Up to 20% on European imports, 36% Thailand, 145% China
  • Class action Feb 2026 over price hikes post-tariffs
  • Mitigation: considering partial production move to the US

3. Warby Parker & DTC Erosion

  • Warby Parker has gained share in entry-level ranges
  • More threat to mass segment than premium

4. Premium Valuation

  • P/E TTM 41.89x leaves little room for error

5. EUR/USD Currency

  • Company reports in EUR; ADR in USD

Conclusion

ESLOY at $122.75 is an opportunity to buy the global eyewear monopoly at a 34% discount from highs, just as:

  • They reported their best year in history (+11.2% revenue)
  • They have the hottest new hardware category (Ray-Ban Meta, 7M units sold)
  • The market punishes them for 2027 fears (Apple) — 18+ months of structural advantage
  • Dividend 1.87% + pricing power to mitigate tariffs
  • Analyst consensus Buy with ~34% upside to target

The boring business (corrective lenses for 2.5B people) anchors the defensive thesis. The exciting business (AI smart glasses) provides the upside.


Research date: Apr 15, 2026 | Next review: Oct 2026

This is not financial advice.

More picks in Consumer Discretionary

See all Consumer Discretionary picks →

More picks from France

See all picks from France →
Researched: Apr 15, 2026Updated: Apr 15, 2026Next review: Oct 15, 2026

This is not financial advice. Consult a certified financial advisor.

The author may hold positions in the securities discussed.

Past performance does not guarantee future results.